Home › BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research
 

Keywords :   


BPS Bioscience, Inc. Introduces New Mutant EZH2 Proteins And Assays Now Available For Cancer And Weaver Syndrome Research

2014-04-30 07:01:39| drugdiscoveryonline News Articles

BPS Bioscience, Inc. (BPS) is excited to announce a unique portfolio of 13 different mutant EZH2 complexes, including several markers for Weaver Syndrome

Tags: research cancer proteins syndrome

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »